ATF3 and cancer: Early studies indicated Cisplatin's anticancer activity was associated with its DNA damaging effects and induction of cancer cell apoptosis [36, 37], that might involve altering various signal transduction pathways, including activating ATF3 signaling pathways [22, 38].